AID/HAT1-mediated epigenetic priming of JAG1/NOTCH signaling drives tumor microenvironment reprogramming in TNBC
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Junna Jiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-In…. Hauptthemen laut MEDLINE: Jagged-1 Protein, Tumor Microenvironment, Epigenesis, Genetic, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) presents a formidable therapeutic challenge due to its aggressive behavior, molecular heterogeneity, and lack of actionable targets. This study identifies activation-induced cytidine deaminase (AID) as a pivotal epigenetic driver reprogramming the tumor microenvironment (TME) via non-canonical regulation of NOTCH signaling. Mechanistically, AID recruits histone acetyltransferase 1 (HAT1) to form a chromatin-remodeling complex that binds the JAG1 promoter region (-1.5 kb to -1.1 kb), inducing H4K5 acetylation and transcriptional activation. This AID/HAT1-JAG1 axis amplifies NOTCH signaling in TNBC models, and genetic ablation of either AID or JAG1 suppresses malignant progression. Pharmacological disruption using 4-Deoxyuricine (AID antagonist) and MG149 (HAT1 inhibitor) reduces JAG1 acetylation, attenuates NOTCH signaling, and reshapes the TME by depleting AID/HAT1-JAG1 axis and enhancing the infiltration of T cells, NK cells, and B cells. Clinically, AID and JAG1 co-expression enhances immune cell infiltration in TME, which predicts poor survival in TNBC cohorts. Our findings redefine AID's role beyond its function in mediating mutagenesis, positioning it as a master epigenetic regulator of TNBC plasticity through acetylation-dependent NOTCH activation. These results resolve the paradox of NOTCH inhibitor resistance by identifying JAG1's epigenetic priming as a prerequisite for ligand-receptor signaling. Targeting the AID/HAT1-JAG1 axis offers a dual therapeutic strategy to overcome TME-mediated therapy resistance and provides a blueprint for precision immunotherapy in AID-positive TNBC subgroups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, Henan 453003,…
- School of Forensic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, People's Republic of China. Electronic address: 201079@xxmu.edu.cn.
- School of Forensic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, People's Republic of China.
- JunJi College, Xinxiang Medical University, Xinxiang, Henan 453003, China.
- Rehabilitation College, XinXiang Medical University, Xinxiang, Henan 453003, People's Republic of China.
- Sanquan College of Xinxiang Medical University, Xinxiang, Henan 453003, China.
Förderung
- Natural Science Foundation of Henan Province
Zitieren
APA
Jiao, J., Lv, Z., Zhang, K., Wang, R., Shi, X., Liu, L., Jiao, J., Niu, Y., & Guo, L. (2025). AID/HAT1-mediated epigenetic priming of JAG1/NOTCH signaling drives tumor microenvironment reprogramming in TNBC. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112118
Vancouver
Jiao J, Lv Z, Zhang K, Wang R, Shi X, Liu L, et al. AID/HAT1-mediated epigenetic priming of JAG1/NOTCH signaling drives tumor microenvironment reprogramming in TNBC. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112118
BibTeX
@article{Jiao2025,
author = {Jiao, Junna and Lv, Zhuangwei and Zhang, Kai and Wang, Ruihan and Shi, Xiaoyu and Liu, Lulu and Jiao, Junyue and Niu, Yi'ang and Guo, Liwei},
title = {AID/HAT1-mediated epigenetic priming of JAG1/NOTCH signaling drives tumor microenvironment reprogramming in TNBC},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112118}
}
EUVIMED